• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INNOVA VASCULAR; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INNOVA VASCULAR; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Model Number 26929
Device Problems Device Dislodged or Dislocated (2923); Material Deformation (2976)
Patient Problem Foreign Body In Patient (2687)
Event Date 11/02/2022
Event Type  Injury  
Event Description
It was reported that the marker band detached during stent deployment and remained in the patient.The patient underwent a peripheral angioplasty procedure of the right lower extremity with pedal access and a 6f non-bsc introducer.The mildly tortuous target lesions were severely calcified, with stenosis measuring 84% in the posterior tibial (pt), 41% in the popliteal artery, and 93% in the superficial femoral artery (sfa).Intravascular ultrasound (ivus) was used to confirm the calcification.The rotapro 1.75 x 135 was selected to open the blockages.The sfa was predilated using a charger 5.0 x 120.The innova 6 x 120 x 130 was then inserted but would not advance all the way to deployment site.The innova was removed undeployed with difficulty.Upon inspection, the tip of the outer retractable deployment sheath appeared burred, and the physician elected to replace the device with another stent rather than reinsert.The patient was then dilated using a coyote 2.5 x 120 balloon.A new innova 6 x 120 x 130 was then inserted without resistance and deployed without any issues.The delivery system was removed without issue.The charger 5.0 x 120 was then used to post dilate the stent.During final imaging, what appeared to be a marker band from the innova delivery system was observed in the patient artery.There was no flow restriction, so the physician elected to leave the marker band in place to avoid possible harm during removal.The area was post dilated with coyote 2.5 x 120 balloon to make sure the marker band was adhered to the wall of the artery.There were no reported adverse patient consequences as a result of the issue.
 
Manufacturer Narrative
Device media analysis: returned product consisted of an innova self-expanding stent system.The outer sheath, tip, inner sheath, and the remainder of the device were checked for damage.Visual examination revealed that the rack was separated at the handle.The proximal section was missing.Microscopic examination revealed no damages.The stent appeared to have been deployed and did not return for analysis.Inspection of the remainder of the device presented no other damage or irregularities.Product analysis could not confirm any issues with the marker band.
 
Event Description
It was reported that the marker band detached during stent deployment and remained in the patient.The patient underwent a peripheral angioplasty procedure of the right lower extremity with pedal access and a 6f non-bsc introducer.The mildly tortuous target lesions were severely calcified, with stenosis measuring 84% in the posterior tibial (pt), 41% in the popliteal artery, and 93% in the superficial femoral artery (sfa).Intravascular ultrasound (ivus) was used to confirm the calcification.The rotapro 1.75 x 135 was selected to open the blockages.The sfa was predilated using a charger 5.0 x 120.The innova 6 x 120 x 130 was then inserted but would not advance all the way to deployment site.The innova was removed undeployed with difficulty.Upon inspection, the tip of the outer retractable deployment sheath appeared burred, and the physician elected to replace the device with another stent rather than reinsert.The patient was then dilated using a coyote 2.5 x 120 balloon.A new innova 6 x 120 x 130 was then inserted without resistance and deployed without any issues.The delivery system was removed without issue.The charger 5.0 x 120 was then used to post dilate the stent.During final imaging, what appeared to be a marker band from the innova delivery system was observed in the patient artery.There was no flow restriction, so the physician elected to leave the marker band in place to avoid possible harm during removal.The area was post dilated with coyote 2.5 x 120 balloon to make sure the marker band was adhered to the wall of the artery.There were no reported adverse patient consequences as a result of the issue.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INNOVA VASCULAR
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer Contact
jay johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key15879822
MDR Text Key304462233
Report Number2124215-2022-47264
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140028
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/20/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/29/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number26929
Device Catalogue Number26929
Device Lot Number0028867477
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/09/2022
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/06/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/14/2022
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age75 YR
Patient SexFemale
-
-